Samuel A Hamood

CIK 1645772 · EVP & CFO · last filed 2026-06-09

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$7.22M

Companies

4

Total Filings

19

Lifetime Open-Market Net

-$19.51M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
DH Director 340,978 $0.84 $286.3K $0 5 2026-06-09
NIQ Director 47,267 $8.27 $390.9K $0 2 2026-06-01
Finch Therapeutics Group, Inc. (FNCH) Delisted Director $7.30 $0 2 2022-06-15
TRU EVP & CFO 98,968 $66.13 $6.54M -$19.51M 10 2017-09-18

Recent Filings · Page 2 of 2

19 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2017-05-03 TRU Sell (S) −145,000 -$5.68M EDGAR
2017-03-17 TRU Mixed +165,052 -$5.23M EDGAR
2017-02-23 TRU Mixed −60,000 -$2.54M EDGAR
2017-02-22 TRU Grant (A) +20,243 $0 EDGAR
2016-11-16 TRU Sell (S) −25,228 -$748.3K EDGAR
2016-09-16 TRU Sell (S) −30,000 -$984.6K EDGAR
2016-08-17 TRU Sell (S) −25,228 -$816.1K EDGAR
2016-05-18 TRU Sell (S) −25,228 -$791.2K EDGAR
2016-02-23 TRU Grant (A) +38,538 $0 EDGAR
Showing 1119 of 19
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.